International patients often discover a hidden problem only after they get home from treatment in China: their insurer can’t process the claim.
The care itself may have been excellent. The surgery may have gone well. The bill may have been far lower than it would have been in the US or Singapore. But then comes the email from the insurer asking for an ICD-10 code, or flagging the diagnosis as unrecognized, and suddenly reimbursement is stuck in limbo.
The issue usually isn’t medical quality. It’s a technical mismatch between the coding system used in Chinese hospitals and the one most international insurers expect.
This is the invisible gap between China’s CCD system and the World Health Organization’s ICD-10 standard. And for cross-border patients, it can mean the difference between a smooth payout and weeks of delays, reviews, or outright denial.
Why the same disease can have two different codes
The global language insurers expect: WHO ICD-10
The World Health Organization’s International Classification of Diseases, 10th Revision, or ICD-10, is the standard language of diagnosis for global insurance workflows. Insurers including Bupa, MSH, Cigna, Aetna, and Allianz use it to determine:
- whether a condition is covered
- whether treatment was medically necessary
- how much to reimburse
In the WHO framework, diseases are grouped into roughly 23,000 base codes. A code like C34, for example, tells an insurer that the patient has a malignant neoplasm of the lung.
What Chinese hospitals actually use: CCD
China doesn’t rely on the WHO’s raw ICD-10 in everyday hospital operations. Instead, hospitals use the Chinese Clinical Diagnosis system, or CCD, formally known as the National Clinical Version of ICD-10.
This isn’t an unofficial workaround. It’s an authorized national expansion designed by China’s National Health Commission to support domestic clinical and administrative needs.
A few details matter here:
- Scale: The National Clinical Version 2.0 contains 34,978 codes, about 51.7% more than the WHO base, with 11,924 added sub-category codes.
- Granularity: A broad WHO code like
I10for primary hypertension may be expanded in China into more detailed variants such asI10.x01orI10.x02, reflecting severity, organ damage, or risk stratification. - Multiple versions: China is simultaneously operating more than 14 ICD-10 variants, including the National Standard (GB/T 14396-2016), the National Clinical Version, Beijing Clinical Version, Shanghai Version, Guangdong Version, and the National Healthcare Security version used in DRG and DIP payment reform.
Why the mismatch turns into denied claims
International insurers process claims through automated rule engines. When those systems encounter a CCD code like I10.x02 or a China-specific surgical extension like 38.5702 for laparoscopic total gastrectomy, the software often can’t interpret it.
That can trigger familiar outcomes:
- Code not found — sending the claim into manual review or denial
- Diagnosis does not support procedure — raising questions about medical necessity
- Invalid ICD-10 — causing immediate rejection
The fragility of these mappings isn’t theoretical. In 2022, a coding-mapping error between China’s National Clinical Version and National Healthcare Security Version caused 40,000 surgical records to disappear from the reimbursement system at Guangdong Provincial People’s Hospital. That case involved domestic payment, but the same structural problem can hit international claims.
The bottom line is simple: Chinese clinicians document care for China’s healthcare system. Your insurer reads claims through the WHO ICD-10 lens. The systems are related, but they are not interchangeable.
Three claim denial patterns international patients should know
1. The congenital-condition trap
A patient in Shanghai undergoes cardiac evaluation. The doctor documents 卵圆孔未闭 and assigns Q21.1, the code for congenital atrial septal defect. The patient’s international policy excludes congenital conditions.
The insurer’s system sees the Q prefix, which falls under WHO’s congenital malformations chapter, and denies the claim automatically.
The nuance is that the condition may have been acquired or clinically insignificant. But once Q21.1 is on the record, the insurer’s decision may become purely mechanical. The physician didn’t necessarily code it incorrectly. The issue is that the code carries different contractual consequences in an international insurance context.
2. The borderline tumor problem
A patient is diagnosed with a borderline serous ovarian tumor, a lesion with low malignant potential. In the Chinese clinical version, the case may be coded as D39.1, a neoplasm of uncertain behavior.
Under strict WHO ICD-10 interpretation, that does not qualify as a malignant tumor in the C00–C97 range. For many critical-illness or high-cost oncology benefits, that distinction matters. The insurer may deny payment because the coded diagnosis is not classified as cancer.
Here, the problem is the gap between clinical nuance and insurance logic. Chinese pathology and coding can recognize gray zones. Many international policies, by contrast, require a C code or a specific ICD-O-3 morphology code of 3/6/9 to unlock benefits.
3. The procedure-description mismatch
A patient receives 腹腔镜下全胃切除术, or laparoscopic total gastrectomy. In China, that may be recorded under a highly specific extension code such as 38.5702.
An international insurer’s system may only recognize a broader ICD-9-CM-3 gastrectomy category and fail to match the laparoscopic detail to its fee schedule. The result is often a stalled claim and a request for the operative report.
This is one of the odd side effects of coding precision. China’s DRG and DIP reforms reward highly detailed procedure coding. International insurers often need broader categories aligned to global standards. More detail can actually create more friction if the receiving system lacks the same level of granularity.
How to protect your claim before, during, and after treatment
Before your visit: pick a hospital that understands international workflows
If you can plan ahead, prioritize hospitals that are more likely to understand cross-border documentation.
Look for Grade 3A public hospitals with International Medical Departments
These departments are specifically designed for foreign patients, diplomats, and commercial insurance holders. They typically offer:
- bilingual coordinators
- English discharge summaries
- direct-billing partnerships
- staff familiar with ICD-10 mapping
Examples named in the source include:
- Peking Union Medical College Hospital in Beijing
- Ruijin Hospital in Shanghai
- Huashan Hospital in Shanghai
- Sun Yat-sen University Cancer Center in Guangzhou
Consider JCI- or CIHA-accredited institutions
JCI accreditation signals alignment with global patient-safety and documentation standards.
CIHA, or Chinese International Hospital Accreditation, is a newer domestic standard developed in parallel to JCI. As of 2026, hospitals including the First Affiliated Hospital of Guangzhou Medical University, Peking University Shenzhen Hospital, and Shenzhen Children’s Hospital had achieved CIHA certification.
That doesn’t automatically solve the CCD versus ICD-10 issue, but it does suggest a stronger commitment to international patient services.
Foreign-owned or joint-venture hospitals may be better equipped
China’s first wholly foreign-owned tertiary hospital, Perennial General Hospital Tianjin, opened in February 2025 and had treated patients from 24 countries by early 2026. Facilities like this are built around international administrative workflows from the start.
During your visit: raise the issue immediately
Chinese physicians in busy public hospitals may see 60 to 100 patients a day. That means you need to be direct and specific early in the consultation.
A practical script from the source text:
Doctor, I am an international patient. My overseas insurer requires WHO-standard ICD-10 codes and English disease names for reimbursement. Could you please use internationally recognized diagnostic terms and the standard WHO ICD-10 code—not the Chinese clinical extension—on my medical record? Thank you.
If you’re receiving Traditional Chinese Medicine or integrated care, ask for a dual-diagnosis format. For example:
- Western diagnosis: Osteoarthritis of knee (
ICD-10: M17) - TCM diagnosis:
痹证(Bi syndrome, qi stagnation & blood stasis)
This helps preserve clinical context while still giving the insurer a recognizable diagnosis code.
What to ask for before the doctor starts typing
Make these requests early:
- Use your passport name exactly on all documents, not a Chinese phonetic transliteration.
- Use a definitive diagnosis where possible, rather than terms like
待查or考虑, unless the evaluation is genuinely incomplete. - Be anatomically specific, including left or right side, exact level such as
L4–L5, acute versus chronic, and benign versus malignant. - Verify the ICD-10 code is a WHO base code, ideally in the standard 4-character form, and not a 6- or 7-character Chinese extension.
Before you leave the hospital: the 8-point checklist
Don’t leave campus until you’ve verified the following:
| # | Check item | Why it matters |
|---|---|---|
| 1 | Passport name matches your travel document exactly | Identity mismatches are a leading cause of administrative delay |
| 2 | Primary diagnosis is a definitive disease name, not just a symptom | Lung adenocarcinoma works; cough or lung mass often won’t |
| 3 | ICD-10 code is present and uses a WHO base code | C34, not C34.x01; I10, not I10.x02 |
| 4 | English diagnosis name appears on the record or discharge summary | Your insurer and home-country physician can read it immediately |
| 5 | Diagnostic basis is documented | CT, MRI, pathology, or biopsy evidence supports medical necessity |
| 6 | Treatment plan is clearly stated | Links the bill to surgery, chemotherapy, or other care |
| 7 | Every page has a physician signature and hospital stamp | Some jurisdictions require this for legal validity |
| 8 | You have a PDF or electronic copy before departure | Paper can be lost, and follow-up from overseas can be difficult |
If you already left China with a CCD-only record
If your documents only include CCD-based coding, there are still steps you can take.
Request a supplementary international discharge summary
Contact the hospital’s Medical Records Department (病案室) or International Office within 30 days and request a supplementary International Discharge Summary with WHO ICD-10 codes mapped from the original CCD record.
The sooner you do this, the easier it usually is to retrieve the underlying data before archiving complicates access.
Use a specialized medical translation firm
If translation is needed, the source recommends using an ISO 17100-certified medical translation firm with clinical coders on staff, not a generic translation agency.
The firm should be able to:
- translate diagnostic terms into WHO-standard English
- produce a crosswalk table from Chinese diagnosis to CCD code to WHO ICD-10 code
- issue a formal certification letter confirming the accuracy of the mapping
Talk to your insurer before they ask
Reach out to the insurer’s pre-authorization team proactively and explain that treatment took place in China and that you’re submitting a CCD-to-ICD-10 mapped record.
Some insurers already maintain internal crosswalks for major Chinese hospitals, especially where direct-billing relationships exist.
The bigger trend: China’s coding system is changing, but slowly
ICD-11 is coming, eventually
China formally reported its intention to adopt ICD-11 to the WHO in 2019. Since then, the National Health Commission has held training workshops in Shenzhen in August 2024 and Haikou in November 2024, while WHO officials visited Beijing in December 2024 to review China’s ICD-11 exam platform.
But nationwide frontline adoption will take time. For now, ICD-10 remains the practical standard for international reimbursement.
CIHA accreditation is expanding
CIHA is gaining momentum as China builds out a domestic accreditation framework for international patient services. In April 2026, Peking University Shenzhen Hospital and Shenzhen Children’s Hospital were among the first to achieve CIHA status.
That won’t erase coding mismatches overnight, but it increases the odds that a hospital has staff who understand international documentation requirements.
Cross-border patient growth is forcing adaptation
The pressure to improve is growing because demand is growing. Shenzhen recorded 770,000 overseas patient visits in 2024. Shanghai’s 13 designated international hospitals saw 270,000 foreign-patient visits in 2025, up 15% year over year.
As the financial stakes rise, both hospitals and insurers have stronger incentives to streamline coding compatibility.
The takeaway: five minutes now can save five weeks later
The Chinese healthcare system isn’t inherently unfriendly to international patients, and international insurers aren’t necessarily trying to block payment. The two sides are simply built on different technical standards.
China’s hospital ecosystem is optimized for domestic clinical precision and DRG or DIP reimbursement. International insurers are optimized for standardized global coding and contractual risk management.
That leaves the patient as the bridge.
Spending five minutes at the start of a consultation to ask for WHO-standard ICD-10 coding, and another ten minutes at discharge to verify your paperwork, can save weeks of follow-up emails, claim delays, and unnecessary stress.
Your medical record isn’t just a clinical summary. In cross-border care, it’s also a financial document. Treat it with the same care as your passport.
Quick reference: common diagnoses and WHO ICD-10 base codes
| Condition | WHO ICD-10 Base Code |
|---|---|
| Primary hypertension | I10 |
| Type 2 diabetes mellitus | E11 |
| Lung cancer (malignant) | C34 |
| Coronary artery disease | I25 |
| Parkinson’s disease | G20 |
| Rheumatoid arthritis | M06 |
| Lumbar disc herniation | M51.1 |
| Cervical spondylosis | M47.8 |
| Acute gastritis | K29 |
| Pneumonia, unspecified | J18.9 |
Always confirm the exact code with your physician, since more specific subclassifications may apply, such as C34.1 for upper lobe or C34.9 for unspecified lung cancer.